UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061000
Receipt number R000069807
Scientific Title Age-stratified disproportionality analysis of gastrointestinal ulcer-related adverse events associated with tramadol and NSAIDs using the Japanese Adverse Drug Event Report (JADER) database
Date of disclosure of the study information 2026/05/01
Last modified on 2026/04/19 09:56:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Age-stratified analysis of gastrointestinal ulcer-related adverse events associated with tramadol and NSAIDs: a study using the JADER database

Acronym

TRAMADOL-GI Risk Study (Signal Analysis)

Scientific Title

Age-stratified disproportionality analysis of gastrointestinal ulcer-related adverse events associated with tramadol and NSAIDs using the Japanese Adverse Drug Event Report (JADER) database

Scientific Title:Acronym

TRAMADOL-GI risk Study

Region

Japan


Condition

Condition

Pain-related conditions affecting the knee, spine, shoulder, hip, and lower extremities

Classification by specialty

Gastroenterology Hepato-biliary-pancreatic medicine Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate age-stratified patterns of gastrointestinal adverse events, including peptic ulcer, gastrointestinal bleeding, and perforation, associated with tramadol use, and to clarify risk characteristics in elderly populations.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Reporting odds ratio (ROR) and 95% confidence interval for gastrointestinal adverse events (including ulcer, bleeding, perforation, necrosis, enteritis, gastritis, and melena) associated with tramadol use in the JADER database (analysis period: entire available dataset)

Key secondary outcomes

1) Reporting odds ratio (ROR) and proportional reporting ratio (PRR) for gastrointestinal adverse events associated with NSAIDs and acetaminophen
2) Comparison of adverse event counts, ROR, and PRR between age groups (20-60 years vs >=70 years)
3) Changes in ROR and PRR based on stratified analyses by concomitant NSAIDs use, antiplatelet/anticoagulant therapy, and renal impairment
4) Exploratory signal detection using empirical Bayes geometric mean (EBGM) and information component (IC)
(analysis period: entire available dataset)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

120 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Cases in the JADER database in which tramadol, tramadol/acetaminophen combination, NSAIDs (e.g., diclofenac, loxoprofen, celecoxib, naproxen), or acetaminophen are reported as suspected drugs
2) Cases with available age information (20-60 years and >=70 years) recorded in the demo table

Key exclusion criteria

1) Cases in which the drug name cannot be clearly identified
2) Cases with missing or unknown age classification (e.g., "unknown", "not reported")

Target sample size

2000


Research contact person

Name of lead principal investigator

1st name Shingo
Middle name
Last name Nemoto

Organization

Aisei Pharmacy Co., Ltd.

Division name

Kanagawa Branch

Zip code

100-0005

Address

Marunouchi Mitsui Building, 2-2-2 Marunouchi, Chiyoda-ku, Tokyo

TEL

03-3240-0222

Email

sentaminami@aisei.co.jp


Public contact

Name of contact person

1st name Shingo
Middle name
Last name Nemoto

Organization

Aisei Pharmacy Co., Ltd.

Division name

Kanagawa Branch

Zip code

100-0005

Address

Marunouchi Mitsui Building, 2-2-2 Marunouchi, Chiyoda-ku, Tokyo

TEL

03-3240-0222

Homepage URL


Email

sentaminami@aisei.co.jp


Sponsor or person

Institute

Aisei Pharmacy Co., Ltd.

Institute

Department

Personal name

Shingo Nemoto


Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Aisei Pharmacy Ethics Review Committee

Address

Marunouchi Mitsui Building, 2-2-2 Marunouchi, Chiyoda-ku, Tokyo

Tel

03-3240-0222

Email

sentaminami@aisei.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 12 Month 04 Day

Date of IRB

2025 Year 12 Month 09 Day

Anticipated trial start date

2026 Year 01 Month 01 Day

Last follow-up date

2026 Year 04 Month 04 Day

Date of closure to data entry

2026 Year 04 Month 11 Day

Date trial data considered complete

2026 Year 04 Month 18 Day

Date analysis concluded

2026 Year 04 Month 25 Day


Other

Other related information

Fill in the tentative dates according to the input format of the UMIN registration format. In this study, the extracted data will be analyzed backward.


Management information

Registered date

2026 Year 03 Month 20 Day

Last modified on

2026 Year 04 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069807